Drug profile · INN
pancrelipase (amylase
PERTZYE
pancrelipase (amylase (PERTZYE) is a fatty acids hydrolytic enzyme. Route of administration: oral. Current US regulatory status: approved.
Drug details — pancrelipase (amylase
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
pancrelipase (amylase (PERTZYE) is a fatty acids hydrolytic enzyme. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Fatty acids hydrolytic enzyme
Primary target: Fatty acids
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is pancrelipase (amylase?
pancrelipase (amylase (PERTZYE) is a fatty acids hydrolytic enzyme. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pancrelipase (amylase?
PERTZYE is a marketed brand name for pancrelipase (amylase. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pancrelipase (amylase?
pancrelipase (amylase has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.